Search

Sally R Postlethwaite

age ~48

from Redwood City, CA

Also known as:
  • Sally Rhiannon Postlethwaite
  • Sally R Lamping
  • Sally Postlethwait
  • Sally T
Phone and address:
2717 Sussex Way, Redwood City, CA 94061
(650)4443340

Sally Postlethwaite Phones & Addresses

  • 2717 Sussex Way, Redwood City, CA 94061 • (650)4443340
  • Truckee, CA
  • San Mateo, CA
  • 2717 Sussex Way, Redwood City, CA 94061

Work

  • Company:
    Applied molecular transport
    Jan 2017
  • Position:
    Principal scientist

Education

  • School / High School:
    Ucl
    1999 to 2003
  • Specialities:
    Engineering, Biochemical Engineering

Skills

Fermentation • Technology Transfer • Biofuels • High Throughput Screening • Biotechnology • Protein Engineering • Fermentation Process Development • Biochemical Engineering • Biocatalysis • Enzymes • Protein Expression • Enzyme Assays • Technical Project Leadership • Filtration • Technical Project Management • Downstream Processing

Industries

Biotechnology

Resumes

Sally Postlethwaite Photo 1

Principal Scientist

view source
Location:
Redwood City, CA
Industry:
Biotechnology
Work:
Applied Molecular Transport
Principal Scientist

Sutro Biopharma, Inc. Sep 2014 - Jan 2017
Senior Scientist, Fermentation and Upstream Process Development

Codexis, Inc. Jan 2012 - Sep 2014
Senior Scientist, Fermentation R and D and Process Development

Codexis, Inc. Oct 2004 - Jan 2012
Staff Scientist, Biocatalyst Evolution and Development
Education:
Ucl 1999 - 2003
University of Cambridge 1995 - 1999
Skills:
Fermentation
Technology Transfer
Biofuels
High Throughput Screening
Biotechnology
Protein Engineering
Fermentation Process Development
Biochemical Engineering
Biocatalysis
Enzymes
Protein Expression
Enzyme Assays
Technical Project Leadership
Filtration
Technical Project Management
Downstream Processing

Us Patents

  • Beta-Glucosidase Variant Enzymes And Related Polynucleotides

    view source
  • US Patent:
    20100317059, Dec 16, 2010
  • Filed:
    Jun 16, 2010
  • Appl. No.:
    12/816989
  • Inventors:
    Sally Rhiannon Postlethwaite - Redwood City CA, US
    Louis Clark - San Francisco CA, US
  • Assignee:
    CODEXIS, INC. - Redwood City CA
  • International Classification:
    C12P 19/00
    C12N 9/42
    C07H 21/04
    C12N 15/63
    C12N 1/21
    C12P 7/06
  • US Classification:
    435 72, 435209, 536 232, 4353201, 43525231, 435161, 43525233
  • Abstract:
    The invention provides variants of the CelA β-glucosidase that have improve β-glucosidase activity, particularly improved thermoactivity, compared to the wild type enzyme. The invention further provides related polynucleotides, vectors, host cell, and methods for making and using the variants.
  • Beta-Glucosidase Variants

    view source
  • US Patent:
    20120077216, Mar 29, 2012
  • Filed:
    Jun 16, 2010
  • Appl. No.:
    13/375189
  • Inventors:
    Xiyun Zhang - Fremont CA, US
    Jie Yang - Foster City CA, US
    Dipnath Baidyaroy - Fremont CA, US
    Sally Rhiannon Postlethwaite - Redwood City CA, US
    Attila Andor - Budapest, HU
    Louis Clark - San Francisco CA, US
    Lisa M. Newman - San Jose CA, US
  • Assignee:
    Codexis, Inc. - Redwood City CA
  • International Classification:
    C12Q 1/34
    C12N 9/42
  • US Classification:
    435 18, 435209
  • Abstract:
    The invention relates to recombinantly produced β-Glucosidase Variants with enhanced thermoactivity compared to naturally occurring proteins. The invention also provides methods for producing a variant β-glucosidase polypeptide with improved thermoactivity by identifying performance sensitive positions in a target β-glucosidase polypeptide and substituting the residue at that position with a thermoactivity enhancing residue.
  • Multi-Cellulase Enzyme Compositions For Hydrolysis Of Cellulosic Biomass

    view source
  • US Patent:
    20120231510, Sep 13, 2012
  • Filed:
    Nov 18, 2010
  • Appl. No.:
    13/508691
  • Inventors:
    Kripa Rao - San Mateo CA, US
    Ish Dhawan - Foster City CA, US
    Sally Postlethwaite - Redwood City CA, US
    Jie Yang - Foster City CA, US
  • Assignee:
    Codexis, Inc. - Redwood City CA
  • International Classification:
    C12N 9/42
    C12P 7/14
    C12P 7/18
    C12P 13/04
    C12P 5/02
    C12P 19/14
    C12P 7/40
  • US Classification:
    435 99, 435209, 435162, 435136, 435106, 435167, 435158
  • Abstract:
    The invention relates to a multi-cellulase enzyme composition for the enzymatic hydrolysis of cellulosic biomass said composition comprising a cellobiohydrolase (CBH) enzyme, an endoglucanase (EG) enzyme and a β-glucosidase (BG) enzyme.
  • Compositions, Formulations And Interleukin Production And Purification

    view source
  • US Patent:
    20210154304, May 27, 2021
  • Filed:
    Feb 5, 2021
  • Appl. No.:
    17/169390
  • Inventors:
    - South San Francisco CA, US
    Randall J. Mrsny - Los Altos Hills CA, US
    Kevin Yin - Palo Alto CA, US
    Tahir Mahmood - Burlingame CA, US
    Bittoo Kanwar - San Francisco CA, US
    Sally Postlethwaite - Redwood City CA, US
    Weijun Feng - Danville CA, US
    Sean Dalziel - South San Francisco CA, US
    Hyojin Kim - San Carlos CA, US
    Rajendra Tandale - Atwater CA, US
    Marvin Garovoy - Sausalito CA, US
    John Koleng - Austin TX, US
  • International Classification:
    A61K 47/34
    C07K 14/54
    A61K 47/38
    A61K 47/32
  • Abstract:
    Described herein are cholix-IL-10 fusion proteins, and methods of use thereof, which can be characterized by a distinct response in an individual when administered. This distinct response can comprise changes in levels of one or more markers in the individual and/or co-localization of IL-10 in the lamina propria of the individual. Further described herein, in some embodiments, are oral formulations of the cholix-IL-10 fusion proteins. Described herein are methods for the purification of an IL-10 delivery construct, including methods for refolding and enrichment, which can result in maintenance of a high percentage of the IL-10 delivery constructs in the biologically active dimer form. Described herein are oral formulations configured for site-specific release of a therapeutic protein in the small intestines or colon. In some cases, the therapeutic protein is in the form of a dimer, such as an IL-10 delivery construct capable of crossing the gut epithelium.
  • Cholix-Derived Carriers For Oral Delivery Of Heterologous Payload

    view source
  • US Patent:
    20210100911, Apr 8, 2021
  • Filed:
    May 27, 2020
  • Appl. No.:
    16/884456
  • Inventors:
    - South San Francisco CA, US
    Charles Olson - South San Francisco CA, US
    Derek Maclean - Los Altos CA, US
    Sally Postlethwaite - Redwood City CA, US
    Amir Porat - Belmont CA, US
  • International Classification:
    A61K 47/64
    C07K 14/195
  • Abstract:
    The present disclosure provides delivery constructs comprising a carrier coupled to a heterologous payload, wherein coupling of the carrier to the payload can result in transportation of the payload (e.g., a therapeutic payload) into and/or across intact polarized epithelial cells (e.g., epithelial cells of the gut of a mammal). The delivery construct can be part of a pharmaceutical composition that can be orally administered to a subject to provide for improved, effective therapies for treatment of, e.g., inflammatory diseases or autoimmune diseases.
  • Beta-Glucosidase Variants

    view source
  • US Patent:
    20150064766, Mar 5, 2015
  • Filed:
    Nov 13, 2014
  • Appl. No.:
    14/540422
  • Inventors:
    - REDWOOD CITY CA, US
    Jie Yang - Foster City CA, US
    Dipnath Baidyaroy - Fremont CA, US
    Sally R. Postlethwaite - Redwood City CA, US
    Attila Andor - Budapest, HU
    Louis A. Clark - San Francisco CA, US
    Lisa Marie Newman - San Jose CA, US
  • International Classification:
    C12N 9/42
  • US Classification:
    435209
  • Abstract:
    The invention relates to recombinantly produced β-glucosidase variants with enhanced thermoactivity compared to naturally occurring proteins. The invention also provides methods for producing a variant β-glucosidase polypeptide with improved thermoactivity by identifying performance sensitive positions in a target β-glucosidase polypeptide and substituting the residue at that position with a thermoactivity enhancing residue.
  • Beta-Glucosidase Variants

    view source
  • US Patent:
    20140256018, Sep 11, 2014
  • Filed:
    May 28, 2014
  • Appl. No.:
    14/289021
  • Inventors:
    - Redwood City CA, US
    Jie Yang - Foster City CA, US
    Dipnath Baidyaroy - Fremont CA, US
    Sally R. Postlethwaite - Redwood City CA, US
    Attila Andor - Budapest, HU
    Louis A. Clark - San Francisco CA, US
    Lisa Marie Newman - San Jose CA, US
  • Assignee:
    Codexis, Inc. - Redwood City CA
  • International Classification:
    C12N 9/24
  • US Classification:
    435200
  • Abstract:
    The invention relates to recombinantly produced β-glucosidase variants with enhanced thermoactivity compared to naturally occurring proteins. The invention also provides methods for producing a variant β-glucosidase polypeptide with improved thermoactivity by identifying performance sensitive positions in a target β-glucosidase polypeptide and substituting the residue at that position with a thermoactivity enhancing residue.

Get Report for Sally R Postlethwaite from Redwood City, CA, age ~48
Control profile